• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Draxis to buy Ivax manufacturing site

Article

Draxis Health has entered into a memorandum of agreement with Ivax to acquire that firm's Kirkland, Quebec, pharmaceutical manufacturing facility. The 238,000-sq-ft facility will serve as the permanent site for Draxis Health's radiopharmaceutical

Draxis Health has entered into a memorandum of agreement with Ivax to acquire that firm's Kirkland, Quebec, pharmaceutical manufacturing facility. The 238,000-sq-ft facility will serve as the permanent site for Draxis Health's radiopharmaceutical subsidiary, Draximage, which announced plans for growth in February (SCAN 2/18/98).

The facility, whose sterile manufacturing department produces prescription pharmaceuticals for the U.S. and Canadian marketplace, is also expected to assume manufacturing responsibilities for the Mississauga, Ontario-based company's SpectroPharm Dermatology product line, as well as Anipryl, the firm's veterinary drug that was recently licensed to Pfizer Animal Health. The acquisition of the facility was expected to close in late March.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.